BEGIN:VCALENDAR
VERSION:2.0
PRODID:talks.ox.ac.uk
BEGIN:VEVENT
SUMMARY:SIR CHARLES SHERRINGTON PRIZE LECTURE: Using vision to understand 
 the brain - Professor Tony Movshon (NYU)
DTSTART;VALUE=DATE-TIME:20260313T130000Z
DTEND;VALUE=DATE-TIME:20260313T140000Z
UID:https://new.talks.ox.ac.uk/talks/id/3e51d7a2-c80a-4eec-8ba9-1e217b1db9
 2a/
DESCRIPTION:As neuroscientists\, we are accustomed to using biological rea
 gents to manipulate neural activity and to discover brain functions. These
  reagents can be drugs\, genetic tools\, light-activated molecules\, and s
 o on. Their use has given us great insights in all areas of neuroscience. 
 Visual neuroscientists have a additional advantage – another set of reag
 ents: visual stimuli. By designing and implementing images and movies with
  particular properties based on the long and rich traditions of visual psy
 chophysics\, we have been able to identify and characterize brain circuits
  that process visual information about pattern\, form\, color\, and motion
 . By using well chosen stimuli\, we can draw strong conclusions about the 
 brain mechanisms of visual information processing. Moreover\, the widespre
 ad influence of visual neuroscience on systems neuroscience more broadly h
 as shown that similar mechanisms play important roles in other brain syste
 ms.\n\nSPEAKER BIOGRAPHY\n\nTony Movshon studies vision and visual percept
 ion\, using a multidisciplinary approach that combines biology\, behavior 
 and theory. His work explores the way that the neural networks in the brai
 n compute and represent the form and motion of objects and scenes\, the wa
 y that these networks contribute to perceptual judgments and to the contro
 l of visually guided action\, and the way that normal and abnormal visual 
 experience influence their development in early life.\n\nMovshon was born 
 and raised in New York\, received his BA and PhD from Cambridge University
 \, and then joined the Department of Psychology at New York University in 
 1975. In 1987 he became founding Director of NYU’s Center for Neural Sci
 ence. Among his honors are the Young Investigator Award from the Society f
 or Neuroscience\, the Rank Prize in Optoelectronics\, the António Champal
 imaud Vision Award\, and the Karl Spencer Lashley Award from the American 
 Philosophical Society. He is a Member of the US National Academy of Scienc
 es\, a Foreign Member of the Royal Society\, and a Fellow of the American 
 Academy of Arts and Sciences\, of the American Association for the Advance
 ment of Science\, and of the Association for Psychological Science.\nSpeak
 ers:\nProfessor Tony Movshon (NYU)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/3e51d7a2-c80a-4eec-8ba9-1e217b1db9
 2a/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR CHARLES SHERRINGTON PRIZE LECTURE: Using vision to un
 derstand the brain - Professor Tony Movshon (NYU)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SHERRINGTON PUBLIC UNDERSTANDING OF SCIENCE PRIZE LECTURE: Media\,
  Science and Truth - Mr Clive Myrie (BBC News)
DTSTART;VALUE=DATE-TIME:20251113T160000Z
DTEND;VALUE=DATE-TIME:20251113T170000Z
UID:https://new.talks.ox.ac.uk/talks/id/8a1bd926-dd45-409b-81f9-f1aacbea1c
 fc/
DESCRIPTION:\nSpeakers:\nMr Clive Myrie (BBC News)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/8a1bd926-dd45-409b-81f9-f1aacbea1c
 fc/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SHERRINGTON PUBLIC UNDERSTANDING OF SCIENCE PRIZE LECTURE
 : Media\, Science and Truth - Mr Clive Myrie (BBC News)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:MARIANNE FILLENZ AWARD LECTURE 2025: Cortical codes for generating
  three-dimensional experience - Professor Kristine Krug (Otto-von-Guericke
  University)
DTSTART;VALUE=DATE-TIME:20251127T130000Z
DTEND;VALUE=DATE-TIME:20251127T140000Z
UID:https://new.talks.ox.ac.uk/talks/id/97db2368-326e-4a5f-84ec-9d4e38a3d0
 21/
DESCRIPTION:Research into the visual cortex of primates has been a pioneer
 ing driver for linking information processing in the brain to cognitive fu
 nction. Sensory input to the system can be tightly controlled and perceptu
 al consequences probed through behavioural report. A detailed understandin
 g of the distributed representations of elements of the visual world has a
 llowed us to predict and modify visual perception. I will argue that the f
 undamental building blocks for our rich visual experience arise from signa
 lling in extrastriate visual cortex. During development\, visual experienc
 e and motor interactions with the world generate internal models of the vi
 sual world by shaping functional local circuits in visual cortex. With foc
 al interventions at specific points in this circuitry\, we can positively 
 and predictively alter visual experience by activating defined circuit ele
 ments that are normally activated by specific content from the visual worl
 d. The more specifically we target visual neurons\, the more predictively 
 and positively we can change visual experience. Using focal microstimulati
 on\, we can artificially reverse the perceived direction of rotation of a 
 3D-object defined by multiple visual cues. Evidence also points to context
 ual factors\, like expected reward and social influence\, biasing visual p
 erception through affecting this local circuitry in visual cortex. The nex
 t frontier is to generate complex visual percepts de novo from artificial 
 signals being planted into cortex without the need for a visual stimulus. 
 One possible approach to achieve this is to look to identify the local spa
 tio-temporal dynamics of neuronal activity that define a specific perceptu
 al state. These are the circuit and the patterns we will have to be able t
 o kick start and employ\, perhaps through multi-site electrical or optogen
 etic stimulation\, in order to build successful cortical neuro-prosthetics
  for 3D and motion vision that would allow blind people to navigate throug
 h space.\n\nSPEAKER BIOGRAPHY\n\nKristine was Marianne Fillenz's last Bach
 elor in Physiological Sciences student at St. Anne's College. Marianne's N
 euroscience and Physiology tutorials and her rigorous focus on experimenta
 l evidence significantly shaped Kristine's scientific journey. After the B
 achelor\, Kristine undertook her DPhil in the University Laboratory of Phy
 siology at Oxford\, researching visual map formation in the visual cortex 
 of hamsters and ferrets with Ian D. Thompson as a Wellcome Prize Scholar. 
 Her thesis received the BNA thesis prize and the Rolleston Memorial Prize 
 from Oxford. After postdoctoral research positions at the Max-Planck-Insti
 tute for biological Cybernetics in Tübingen\, Germany and Oxford\, where 
 she worked on the neural mechanisms of 3D visual processing in the macaque
  brain\, she held Royal Society Dorothy Hodgkin and University Research Fe
 llowships at DPAG. In 2014\, she was promoted to Associate Professor in Ne
 uroscience. Kristine moved in 2019 to the Otto-von-Guericke-University and
  the Leibniz-Institute in Neurobiology in Magdeburg\, Germany as Heisenber
 g- Professor (DFG) and Chair in Sensory Physiology. The main focus of her 
 research is to elucidate the neuronal signals and interactions that shapes
  our vivid perceptual experience of the dynamic\, three-dimensional world 
 around us.\nSpeakers:\nProfessor Kristine Krug (Otto-von-Guericke Universi
 ty)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/97db2368-326e-4a5f-84ec-9d4e38a3d0
 21/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:MARIANNE FILLENZ AWARD LECTURE 2025: Cortical codes for g
 enerating three-dimensional experience - Professor Kristine Krug (Otto-von
 -Guericke University)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR CHARLES SHERRINGTON PRIZE LECTURE: May the Force Be with You: 
 PIEZO Ion Channels as Essential Pressure Sensors for Touch\, Pain\, and Be
 yond - Professor Ardem Patapoutian (Howard Hughes Medical Institute)
DTSTART;VALUE=DATE-TIME:20251204T160000Z
DTEND;VALUE=DATE-TIME:20251204T170000Z
UID:https://new.talks.ox.ac.uk/talks/id/233d568f-9044-4611-a23e-6173b9b648
 23/
DESCRIPTION:Mechanotransduction was perhaps the last major sensory modalit
 y not understood at the molecular level. Proteins/ion channels that sense 
 mechanical force are postulated to play critical roles in sensing touch/pa
 in (somatosensation)\, sound (hearing)\, shear stress (cardiovascular func
 tion)\, etc.\; however\, the identity of ion channels involved in sensing 
 mechanical force had remained elusive. The Patapoutian lab identified PIEZ
 O1 and PIEZO2\, mechanically-activated cation channels that are expressed 
 in many mechanosensitive cell types. Genetic studies established that PIEZ
 O2 is the principal mechanical transducer for touch\, proprioception\, bar
 oreception and bladder & lung stretch\, and that PIEZO1 mediates blood-flo
 w sensing\, which impacts vascular development and iron homeostasis. Clini
 cal investigations have confirmed the importance of these channels in huma
 n physiology. \n\nSPEAKER BIOGRAPHY\n\nArdem Patapoutian is an American sc
 ientist of Armenian origin. He is molecular biologist specializing in sens
 ory transduction. His research has led to the identification of receptors 
 activated by temperature and pressure. His laboratory has shown that these
  ion channels play crucial roles in sensing temperature\, touch\, proprioc
 eption\, pain\, and blood presssure. Patapoutian was born in Lebanon in 19
 67 and attended the American University of Beirut for one year before he i
 mmigrated to The United States in 1986 and became a US citizen. He graduat
 ed from UCLA in 1990 and received his Ph.D. at Caltech in 1996. After post
 doctoral work with Dr. Lou Reichardt at UCSF\, he joined the faculty of Sc
 ripps Research in 2000\, where he currently holds the Presidential Endowed
  Chair and is a Professor in the Department of Neuroscience. Patapoutian w
 as awarded the Young Investigator Award from the Society for Neuroscience 
 in 2006 and was named an Investigator of the Howard Hughes Medical Institu
 te in 2014. He is a fellow of the American Association for the Advancement
  of Science (2016)\, a member of the National Academy of Sciences (2017) a
 nd a member of American Academy of Arts and Sciences (2020). He is a co-re
 cipient of the 2017 Alden Spencer Award from Columbia\, the 2019 Rosenstie
 l Award for Distinguished Work in Basic Medical\, the 2020 Kavli Prize in 
 Neuroscience\, and the 2021 Nobel Prize in Physiology or Medicine.\nSpeake
 rs:\nProfessor Ardem Patapoutian (Howard Hughes Medical Institute)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/233d568f-9044-4611-a23e-6173b9b648
 23/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR CHARLES SHERRINGTON PRIZE LECTURE: May the Force Be w
 ith You: PIEZO Ion Channels as Essential Pressure Sensors for Touch\, Pain
 \, and Beyond - Professor Ardem Patapoutian (Howard Hughes Medical Institu
 te)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:PAEDIATRICS\, KAVLI & DPAG SPECIAL LECTURE: Bespoke CRISPR Gene Ed
 iting Therapies at Nationwide Scale: an Actionable Path - Professor Fyodor
  Urnov (University of California\, Berkeley)
DTSTART;VALUE=DATE-TIME:20250707T160000
DTEND;VALUE=DATE-TIME:20250707T170000
UID:https://new.talks.ox.ac.uk/talks/id/c81027ff-c8e3-4e30-8d8e-3bd5bdf74b
 31/
DESCRIPTION:SPEAKER BIOGRAPHY\n\nFyodor Urnov is the Director for Technolo
 gy and Translation at the Innovative Genomics Institute and a Professor of
  Molecular Therapeutics in the Department of Molecular and Cell Biology at
  UC Berkeley. Most recently he was the IGI lead on the collaboration that 
 enabled the world's first CRISPR-on-demand medicine for an infant with a s
 evere genetic disease of metabolism (New England Journal of Medicine 392:2
 235). In a quarter-century career in genetic medicine Fyodor co-developed 
 the toolbox of human genome and epigenome editing\, co-named genome editin
 g\, and was on the team that advanced all of its first-in-human applicatio
 ns to the clinic. He also led the effort that identified the genome editin
 g target for an approved medicine to treat sickle cell disease and beta-th
 alassemia. A major goal for the field of genome editing and a key focus of
  Fyodor’s work is expanding access to CRISPR therapies for genetic disea
 se. As part of that effort Fyodor directs the Danaher-IGI Beacon for CRISP
 R Cures – a first-in-class academia-industry partnership developing and 
 advancing to the clinic scalable CRISPR-based approaches to treat diseases
  of the immune system that found its first reduction to clinical practice 
 in the CRISPR-on-demand effort this year. Fyodor also leads cross-function
 al teams in developing and advancing to the clinic CRISPR-based approaches
  to treat neurodegenerative\, neuroinflammatory\, and infectious diseases\
 , and is the IGI lead in the MRC Center for Research Excellence in Therape
 utic Genomics.\nSpeakers:\nProfessor Fyodor Urnov (University of Californi
 a\, Berkeley)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/c81027ff-c8e3-4e30-8d8e-3bd5bdf74b
 31/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:PAEDIATRICS\, KAVLI & DPAG SPECIAL LECTURE: Bespoke CRISP
 R Gene Editing Therapies at Nationwide Scale: an Actionable Path - Profess
 or Fyodor Urnov (University of California\, Berkeley)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:DPAG KAVLI SIR HANS KREBS PRIZE LECTURE 2025: Advances in Drug Del
 ivery and Tissue Engineering: Towards Oral Insulin and Artificial Pancreas
  - Professor Robert Langer (Massachusetts Institute of Technology)
DTSTART;VALUE=DATE-TIME:20250624T160000
DTEND;VALUE=DATE-TIME:20250624T170000
UID:https://new.talks.ox.ac.uk/talks/id/996f2bb1-cefb-481a-83b7-86ee2cf14a
 27/
DESCRIPTION:Advanced drug delivery systems are having an enormous impact o
 n human health. We start by discussing our early research on developing th
 e first controlled release systems for macromolecules and the isolation of
  angiogenesis inhibitors and how these led to numerous new therapies inclu
 ding treatments for diabetic retinol. This early research then led to new 
 drug delivery technologies including nanoparticles and nanotechnology that
  are now being studied for use treating cancer\, other illnesses and in va
 ccine delivery (including the Covid-19 vaccine). We are also developing or
 al systems that can deliver insulin and other macromolecules. Finally\, by
  combining mammalian cells\, including stem cells\, with synthetic polymer
 s\, new approaches for engineering tissues are being developed that may so
 meday help in various diseases. Examples in the areas of pancreas mcartila
 ge\, skin\, blood vessels and heart tissue are discussed.\n\nSPEAKER BIOGR
 APHY\n\nDr. Bob Langer is one of nine Institute Professors at the Massachu
 setts Institute of Technology (MIT)\, MIT’s highest faculty honor. His p
 ioneering work\, which has benefited millions worldwide\, includes isolati
 ng the first angiogenesis inhibitors (with Dr. Judah Folkman) leading to n
 ew treatments for cancer and blindness. He also created the first nanopart
 icles and microparticles for delivering large molecules\, including nuclei
 c acids and helped establish the field of tissue engineering which enabled
  artificial skin for burn victims and organ-on-a-chip technology. Despite 
 initial skepticism—his first nine grants were rejected\, and no engineer
 ing department would hire him—Langer has authored more than 1\,600 paper
 s\, cited more than 446\,690 times. With an h-index of 331\, Langer is the
  most cited engineer in history. His patents have been licensed or sublice
 nsed to over 400 companies and he has co-founded more than 40 ventures\, i
 ncluding Moderna.\n\nLanger chaired the FDA’s Science Board from 1999–
 2002 and has received over 220 awards\, including the U.S. National Medal 
 of Science and the National Medal of Technology and Innovation (one of onl
 y three living individuals to receive both). His accolades include the Dra
 per Prize (considered engineering’s Nobel Prize)\, Queen Elizabeth Prize
  for Engineering\, Albany Medical Center Prize\, Breakthrough Prize in Lif
 e Sciences\, Kyoto Prize\, Wolf Prize\, Millennium Technology Prize\, and 
 the Kavli Prize. He holds 44 honorary doctorates from institutions such as
  Harvard\, Yale\, Columbia and Oxford and has been elected to the National
  Academies of Medicine\, Engineering and Sciences\, as well as the Nationa
 l Academy of Inventors.\nSpeakers:\nProfessor Robert Langer (Massachusetts
  Institute of Technology)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/996f2bb1-cefb-481a-83b7-86ee2cf14a
 27/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:DPAG KAVLI SIR HANS KREBS PRIZE LECTURE 2025: Advances in
  Drug Delivery and Tissue Engineering: Towards Oral Insulin and Artificial
  Pancreas - Professor Robert Langer (Massachusetts Institute of Technology
 )
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SHERRINGTON PUBLIC UNDERSTANDING OF SCIENCE PRIZE LECTURE: The Art
  of Choosing - Professor Sheena S. Iyengar (Columbia Business School)
DTSTART;VALUE=DATE-TIME:20250522T160000
DTEND;VALUE=DATE-TIME:20250522T170000
UID:https://new.talks.ox.ac.uk/talks/id/ee811723-6809-4444-81d1-1f74f08795
 10/
DESCRIPTION:From what time we wake up to what we choose to wear to whom we
  marry\, choice is a defining feature of the human experience. Sheena Iyen
 gar\, S.T. Lee Professor of Business at Columbia Business School\, has spe
 nt decades studying the cognitive and behavioral mechanisms behind decisio
 n-making—why we choose\, how choices impact our happiness\, and whether 
 more choices empower or overwhelm us. Blending empirical research with rea
 l-world applications\, Iyengar challenges common assumptions to show how c
 omplex our decision-making processes truly are. Are more choices enablin
 g or crippling? Does careful planning always help us make better decisio
 ns? How does our environment affect our preferences? Her research spans 
 healthcare\, consumer behavior\, medicine\, leadership\, and innovation to
  uncover the hidden dynamics of choice. By deepening our understanding of 
 the forces that drive decisions\, Iyengar equips us to choose with greater
  awareness\, confidence\, and clarity—whether that means exercising our 
 freedom to choose well or recognizing when we would rather not choose at a
 ll.  \n\nSPEAKER BIOGRAPHY\n\nSheena S. Iyengar is the S.T. Lee Profes
 sor of Business and the Academic Director of the Innovation Hub at the Col
 umbia Business School. She is one of the world’s experts on choice and i
 nnovation. \nIyengar is the recipient of the Thinkers50 2023 Innovation Aw
 ard and the author of two award-winning books\, The Art of Choosing (2010 
 Financial Times Business Book of the Year and #3 Bestselling Business Book
  on Amazon) and Think Bigger: How to Innovate (2023 Gold Medal recipient f
 or the Axiom Business Book Awards and Thinkers50 Top 10 Management Book of
  the Year). Her recorded TED Talks have received a collective 7 million vi
 ews. She regularly appears in top tier media such as The Wall Street Journ
 al\, the Financial Times\, The New Yorker\, The Economist\, Bloomberg Busi
 nessweek\, CNBC\, CNN\, The BBC\, and NPR. \nIyengar is famously recognize
 d her “Jam Study\,” which revolutionized how we approach product offer
 ings and customer curation. The study revealed that too many choices reduc
 e customer purchasing and corporate growth. Since then\, over 1\,000 studi
 es on choice overload have been conducted\, leading to the widely recogniz
 ed 80/20 rule\, which shows that 80% of a company’s outcomes (outputs an
 d revenue) come from 20% of causes (inputs and choices). Leveraging her ex
 pertise in choice\, Iyengar has advised hundreds of companies across busin
 ess\, technology\, consumer retail\, media\, consulting\, investing\, and 
 STEM\, helping them transform decision-making and enhance stakeholder expe
 riences.\nIyengar created the Think Bigger method for innovative thinking 
 and problem-solving based on recent advances in neuro- and cognitive scien
 ces. Where prevailing methods for innovation\, such as Design Thinking\, t
 each customer research and feedback methods\, Think Bigger concentrates on
  how creative ideas form in your mind and teaches a six-step process for i
 nnovation.  \nIn 2024\, Iyengar was awarded the Society of Experimental So
 cial Psychology (SESP) Scientific Impact Award. She was ranked by the Thin
 kers50 as a Top 10 Management Thinker in 2023. In 2022\, Iyengar was ranke
 d by the Asian American Business Development Center as one of the 50 Outst
 anding Asian Americans in Business. She received the Outstanding Faculty A
 ward from the CBS Executive MBA Class of 2021. In 2012\, Iyengar was recog
 nized by Poets and Quants as one of the Best Business School Professors fo
 r her work merging academia with practice. In 2002\, she was the only soci
 al scientist to receive the Presidential Early Career Award for Scientists
  and Engineers from the Office of the President. \nIyengar holds a dual de
 gree from the University of Pennsylvania\, with a BS in Economics from the
  Wharton School and a BA in psychology from the College of Arts and Scienc
 es. She received her PhD from Stanford University. \nIn her personal life\
 , as a blind woman\, Iyengar intuitively used Think Bigger to find her cal
 ling and strives to inspire others to do the same. \nSpeakers:\nProfessor 
 Sheena S. Iyengar (Columbia Business School)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/ee811723-6809-4444-81d1-1f74f08795
 10/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SHERRINGTON PUBLIC UNDERSTANDING OF SCIENCE PRIZE LECTURE
 : The Art of Choosing - Professor Sheena S. Iyengar (Columbia Business Sch
 ool)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:BURDON SANDERSON PRIZE LECTURE: Targeting calcium leak to treat di
 sorders of heart\, muscle and brain - Professor Andrew R. Marks (Columbia 
 University)
DTSTART;VALUE=DATE-TIME:20250520T160000
DTEND;VALUE=DATE-TIME:20250520T170000
UID:https://new.talks.ox.ac.uk/talks/id/9d15e879-c705-4e21-b76d-5c658c08e8
 e5/
DESCRIPTION:\nCalcium (Ca2+) is a requisite second messenger in all living
  organisms. From C. elegans to mammals\, Ca2+ is necessary for locomotion\
 , bodily functions\, and neural activity. However\, too much of a good thi
 ng can be bad. Intracellular Ca2+ overload can result in loss of function 
 and death. Intracellular Ca2+ release channels evolved to safely provide l
 arge\, rapid Ca2+ signals without exposure to toxic extracellular Ca2+. Ry
 anodine receptors (RyRs) are intracellular Ca2+ release channels present t
 hroughout the zoosphere. Over the past 35 years\, our knowledge of RyRs ha
 s advanced to the level of atomic-resolution structures revealing their ro
 le in the mechanisms underlying the pathogenesis of human disorders of hea
 rt\, muscle\, and brain. Stress-induced RyR-mediated intracellular Ca2+ le
 ak in the heart can promote heart failure and cardiac arrhythmias. In skel
 etal muscle\, RyR1 leak contributes to muscle weakness in inherited myopat
 hies\, to age-related loss of muscle function and cancer-associated muscle
  weakness\, and to impaired muscle function in muscular dystrophies\, incl
 uding Duchenne. In the brain\, leaky RyR channels contribute to cognitive 
 dysfunction in Alzheimer’s disease\, posttraumatic stress disorder\, and
  Huntington’s disease. Novel therapeutics targeting dysfunctional RyRs a
 re showing promise.\n\nSpeakers:\nProfessor Andrew R. Marks (Columbia Univ
 ersity)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/9d15e879-c705-4e21-b76d-5c658c08e8
 e5/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:BURDON SANDERSON PRIZE LECTURE: Targeting calcium leak to
  treat disorders of heart\, muscle and brain - Professor Andrew R. Marks (
 Columbia University)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR CHARLES SHERRINGTON PRIZE LECTURE: New Insights into Basic Mec
 hanisms of Synaptic Neurotransmission - Professor James E. Rothman (Yale U
 niversity School of Medicine)
DTSTART;VALUE=DATE-TIME:20250507T160000
DTEND;VALUE=DATE-TIME:20250507T170000
UID:https://new.talks.ox.ac.uk/talks/id/4d8a71ee-b758-47f9-9bc1-2447fcf3c7
 cd/
DESCRIPTION:The ultra-fast release of neurotransmitters sets the pace of c
 ognition. Synchronous release has now been reconstituted from pure protein
 s. The results are surprising mechanistic insights into the extraordinary 
 speed of the process and the structures underpinning it.\nSpeakers:\nProfe
 ssor James E. Rothman (Yale University School of Medicine)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/4d8a71ee-b758-47f9-9bc1-2447fcf3c7
 cd/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR CHARLES SHERRINGTON PRIZE LECTURE: New Insights into 
 Basic Mechanisms of Synaptic Neurotransmission - Professor James E. Rothma
 n (Yale University School of Medicine)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR WILFRID LE GROS CLARK PRIZE LECTURE 2025: Phase separation in 
 cell physiology and disease - Professor Tony Hyman (Max Planck Institute o
 f Molecular Cell Biology and Genetics)
DTSTART;VALUE=DATE-TIME:20250306T160000Z
DTEND;VALUE=DATE-TIME:20250306T170000Z
UID:https://new.talks.ox.ac.uk/talks/id/a9b91d03-a2fb-4187-8164-0ff15c8837
 e9/
DESCRIPTION:Cells organize many of their biochemical reactions by formatio
 n and dissolution of non-membrane-bound compartments. Recent experiments s
 how that one common mechanism for such biochemical organization is phase s
 eparation of disordered proteins to form compartments with liquid properti
 es.  These compartments can subsequently harden to form compartments with 
 new material properties such as gels and glasses. These compartments can b
 e described by principles elucidated from condensed-matter physics and are
  therefore termed biomolecular condensates.  I will discuss potential role
 s of phase separation in organization and robustness of cellular biochemis
 try and how they fail in disease.\nSpeakers:\nProfessor Tony Hyman (Max Pl
 anck Institute of Molecular Cell Biology and Genetics)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/a9b91d03-a2fb-4187-8164-0ff15c8837
 e9/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR WILFRID LE GROS CLARK PRIZE LECTURE 2025: Phase separ
 ation in cell physiology and disease - Professor Tony Hyman (Max Planck In
 stitute of Molecular Cell Biology and Genetics)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:MABEL FITZGERALD PRIZE LECTURE 2025: Dendrites in Motor control an
 d learning - Professor Jackie Schiller (Technion - Israel Institute of Tec
 hnology)
DTSTART;VALUE=DATE-TIME:20250305T130000Z
DTEND;VALUE=DATE-TIME:20250305T140000Z
UID:https://new.talks.ox.ac.uk/talks/id/6e6ccf4f-59a5-4d66-98b8-0c7f668852
 e2/
DESCRIPTION:Understanding the input-output function of principal cortical 
 neurons and its role in network dynamics is a critical step toward deciphe
 ring how information is represented and encoded in the cortex. Pyramidal n
 eurons act as sophisticated computational units\, integrating the activity
  of thousands of synaptic inputs into a coherent output pattern. These com
 putations largely occur in their elaborate dendritic trees\, which receive
  these synaptic inputs and transform them into neural codes. However\, the
  specific computations performed by dendrites in vivo during behaviorally 
 relevant tasks remain poorly understood.\nIn this talk\, I will present ou
 r findings on the dendritic mechanisms employed by layer 5 pyramidal tract
  (PT) neurons to encode motor information in vivo during dexterous motor t
 asks. By employing two-photon calcium imaging in head-fixed mice performin
 g various motor tasks\, alongside an experimental and analysis pipeline we
  developed\, we achieved an unprecedented resolution in correlating the st
 ructural features of dendritic trees with their functional outputs.\nOur r
 esults reveal that the dendrites of PT neurons exhibit highly localized an
 d independent activity\, storing distinct motor memories in specific dendr
 itic compartments and generating parallel signals to control different asp
 ects of movement. Additionally\, I will present new data illustrating how 
 motor information is reorganized within the dendrites of PT neurons during
  motor learning\, and I will highlight the types of inputs that contribute
  to this process.\nSpeakers:\nProfessor Jackie Schiller (Technion - Israel
  Institute of Technology)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/6e6ccf4f-59a5-4d66-98b8-0c7f668852
 e2/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:MABEL FITZGERALD PRIZE LECTURE 2025: Dendrites in Motor c
 ontrol and learning - Professor Jackie Schiller (Technion - Israel Institu
 te of Technology)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:BURDON SANDERSON PRIZE LECTURE 2024: Deciphering the mysteries of 
 sleep: toward the molecular substrate for “sleepiness” - Dr Masashi Ya
 nagisawa (University of Tsukuba)
DTSTART;VALUE=DATE-TIME:20241022T160000
DTEND;VALUE=DATE-TIME:20241022T170000
UID:https://new.talks.ox.ac.uk/talks/id/1e8c1529-de34-4bd7-a1ec-50f56028b5
 46/
DESCRIPTION:Although sleep is a ubiquitous behavior in animal species with
  a nervous system\, many aspects in the neurobiology of sleep remain myste
 rious. Our discovery of orexin\, a hypothalamic neuropeptide involved in t
 he maintenance of wakefulness\, has triggered intensive research examining
  the exact role of the orexinergic and other neuronal pathways in the regu
 lation of sleep/wakefulness. Orexin receptor antagonists\, which specifica
 lly block the endogenous waking system\, have been approved as a new drug 
 to treat insomnia. Also\, since the sleep disorder narcolepsy-cataplexy is
  caused by orexin deficiency\, orexin receptor agonists are expected to pr
 ovide mechanistic therapy for the disease\; they will likely be also usefu
 l for treating excessive sleepiness due to other etiologies.\nEven though 
 the executive neurocircuitry and neurochemistry for sleep/wake switching\,
  including the orexinergic system\, has been increasingly revealed in rece
 nt years\, the mechanism for homeostatic regulation of sleep\, as well as 
 the neural substrate for "sleepiness" (sleep pressure)\, remains unknown. 
 To crack open this black box\, we have initiated a large-scale forward gen
 etic screen of sleep/wake phenotype in mice based on true somnographic (EE
 G/EMG) measurements. We have so far screened >10\,000 heterozygous ENU-mut
 agenized founders and established several pedigrees exhibiting heritable a
 nd specific sleep/wake abnormalities. By combining linkage analysis and th
 e next-generation whole exome sequencing\, we have molecularly identified 
 and verified the causal mutation in several of these pedigrees. Since thes
 e dominant mutations cause strong phenotypic traits\, we expect that the m
 utated genes will provide new insights into the elusive pathway regulating
  sleep/wakefulness. Indeed\, through a systematic cross-comparison of the 
 SIK3 Sleepy mutants and sleep-deprived mice\, we have found that the cumul
 ative phosphorylation state of a specific set of mostly synaptic proteins 
 may represent the molecular substrate of sleep pressure. We have also foun
 d that the neuronal molecular pathway LKB1-SIK3-HDAC4/5 may represent the 
 level of sleep pressure\, regulating the amount\, depth\, and timing of sl
 eep by acting in different brain regions\, respectively (Kim et al. Nature
  612: 512-518\, 2022\; Zhou et al. Nature 612: 519-527\, 2022).\nSpeakers:
 \nDr Masashi Yanagisawa (University of Tsukuba)
LOCATION:Sherrington Building (Blakemore Lecture Theatre)\, off Parks Road
  OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/1e8c1529-de34-4bd7-a1ec-50f56028b5
 46/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:BURDON SANDERSON PRIZE LECTURE 2024: Deciphering the myst
 eries of sleep: toward the molecular substrate for “sleepiness” - Dr M
 asashi Yanagisawa (University of Tsukuba)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:MABEL FITZGERALD PRIZE LECTURE 2024: Structure to function - some 
 stories from the cell surface - Professor E. Yvonne Jones\, FRS (Universit
 y of Oxford)
DTSTART;VALUE=DATE-TIME:20241128T130000Z
DTEND;VALUE=DATE-TIME:20241128T140000Z
UID:https://new.talks.ox.ac.uk/talks/id/43fcea74-a115-4580-a440-30124f8c74
 3f/
DESCRIPTION:In my laboratory we combine x-ray crystallographic and cryoEM 
 based analyses with biophysical and functional studies to study the assemb
 ly and modulation of cell surface signalling complexes involved in develop
 ment and tissue homeostasis. We aim to generate mechanistic insights\, at 
 atomic resolution\, which can be tested by functional studies in vitro and
  in vivo. Through interdisciplinary collaborations we have integrated mech
 anistic insight with functional context in fly\, zebrafish and mouse model
  systems. I will discuss some of the recent results we have generated by a
 pplying this approach to the signalling mechanism of the semaphorin-plexin
  cell guidance system and to the extracellular modulation of signalling by
  the morphogen Wnt. Published examples of our work on these two systems in
 clude the following:\n\nG.T. Powell=\, A. Faro=\, Y. Zhao=*\, H. Stickney=
 \, L. Novellasdemunt\, P. Henriques\, G. Gestri\, E. Redhouse White\, J. R
 en\, W. Lu\, R.M. Young\, T.A. Hawkins\, F. Cavodeassi\, Q. Schwarz\, E. D
 reosti\, D.W. Raible\, V.S.W. Li\, G.J. Wright\, E.Y. Jones*\, S.W. Wilson
 *. (2024) ‘Cachd1 is a novel Frizzled- and LRP6-interacting protein requ
 ired for neurons to acquire left-right asymmetric character.’ Science 38
 4\, 573-579.\n\nV. Mehta\, K.L. Pang\, D. Rozbesky\, K. Nather\, A. Keen\,
  D. Lachowski\, Y. Kong\, D. Karia\, M. Ameismeier\, J. Huang\, Y. Fang\, 
 A. del Rio Hernandez\, J.S. Reader\, E.Y. Jones and E. Tzima*. (2020) ‘T
 he Guidance Receptor Plexin D1 is a mechanosensor in endothelial cells.’
  Nature 578\, 290-295.\n\nI.J. McGough=\, L. Vecchia=\, B. Bishop\, T. Mal
 inauskas\, K. Beckett\, D. Joshi\, N. O'Reilly\, C. Siebold\, E.Y. Jones* 
 and J-P. Vincent*. (2020) ‘Glypicans shield the Wnt lipid moiety to enab
 le signalling at a distance.’ Nature 585\, 85-90\nSpeakers:\nProfessor E
 . Yvonne Jones\, FRS (University of Oxford)
LOCATION:Sherrington Building (Blakemore Lecture Theatre\, Sherrington Bui
 lding)\, off Parks Road OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/43fcea74-a115-4580-a440-30124f8c74
 3f/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:MABEL FITZGERALD PRIZE LECTURE 2024: Structure to functio
 n - some stories from the cell surface - Professor E. Yvonne Jones\, FRS (
 University of Oxford)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR HANS KREBS PRIZE LECTURE: From base change to better care in d
 iabetes - Prof Andrew Hattersley (University of Exeter)
DTSTART;VALUE=DATE-TIME:20240509T160000
DTEND;VALUE=DATE-TIME:20240509T170000
UID:https://new.talks.ox.ac.uk/talks/id/7f383936-aaed-4667-ad0d-6e4a66076e
 f5/
DESCRIPTION:SPEAKER BIOGRAPHY\n\nProfessor Andrew Hattersley is the Profes
 sor of Molecular Medicine at the University of Exeter\, UK and a practicin
 g consultant diabetologist at the Royal Devon and Exeter hospital. He trai
 ned in Medicine at the Universities of Cambridge and Oxford. His postgradu
 ate education was in London\, Oxford and Birmingham. \n\nWorking with Prof
 essor Sian Ellard he has taken Exeter from being a centre with no genetics
  laboratory in 1995 to now being the top international laboratory for mono
 genic diabetes with over 25\,000 referrals from 108 countries.  They have 
 discovered 27 genes which when mutated cause monogenic diabetes.Importantl
 y he has gone on from gene discovery to find the best treatment for monoge
 nic diabetes. He has shown that the commonest forms of both familial genet
 ic diabetes and neonatal diabetes can be treated with tablets instead of i
 nsulin resulting in better blood sugar control.  Recent work has focused o
 n “Precision Diabetes” identifying subgroups in Type 1 and Type 2 diab
 etes with different treatment responses. \n\nHe has published over 600 pap
 ers with over 110\,000 citations\, given over 350 national and internation
 al lecturers and received many international and national awards for his w
 ork including being appointed as a fellow of The Royal Society and being a
 warded a CBE.\nSpeakers:\nProf Andrew Hattersley (University of Exeter)
LOCATION:Sherrington Building (Blakemore Lecture Theatre\, Sherrington Bui
 lding)\, off Parks Road OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/7f383936-aaed-4667-ad0d-6e4a66076e
 f5/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR HANS KREBS PRIZE LECTURE: From base change to better 
 care in diabetes - Prof Andrew Hattersley (University of Exeter)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR CHARLES SHERRINGTON PRIZE LECTURE: Scents and Sensibility: Rep
 resentations of Identity\, Illusion and Value in Olfactory Cortex - Profes
 sor Richard Axel (Columbia University)
DTSTART;VALUE=DATE-TIME:20240429T160000
DTEND;VALUE=DATE-TIME:20240429T170000
UID:https://new.talks.ox.ac.uk/talks/id/a731a8f4-f778-473d-97d5-c53923ea9b
 3f/
DESCRIPTION:SPEAKER BIOGRAPHY\n\nRichard Axel is a Nobel laureate\, a Univ
 ersity Professor\, and Investigator at the Howard Hughes Medical Institute
  and Columbia University Medical Center\, and a codirector of Columbia’s
  Mortimer B. Zuckerman Mind Brain Behavior Institute. Dr. Axel obtained an
  AB from Columbia College and an MD from Johns Hopkins Medical School. In 
 earlier studies\, Dr. Axel and his colleagues\, Michael Wigler and Saul Si
 lverstein\, developed gene transfer techniques that permit the introductio
 n of virtually any gene into any cell. These studies not only allowed for 
 a novel approach to isolate genes but also provided a detailed analysis of
  how they worked. At the same time\, these experiments allowed for the pro
 duction of an increasingly large number of clinically important proteins. 
 These studies also led to the isolation and functional analysis of a gene 
 for the lymphocyte surface protein\, CD4\, the cellular receptor for the A
 IDS virus\, HIV. Professor Axel interested in the neurobiology of olfactio
 n\, or the sense of smell. He wants to understand the representation of ol
 factory information in the brain and the neural mechanisms that translate 
 these representations into appropriate innate and learned behavioral respo
 nses. Working in the mouse and Drosophila\, Axel and his team seek to gene
 tically and physiologically dissect the sensory coding of odors. Their stu
 dies reveal that the anatomic organization and functional logic of olfacto
 ry circuits in Drosophila and mammals are remarkably similar\, despite the
  organisms’ evolutionary distance from one another.\nSpeakers:\nProfesso
 r Richard Axel (Columbia University)
LOCATION:Sherrington Building (Blakemore Lecture Theatre\, Sherrington Bui
 lding)\, off Parks Road OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/a731a8f4-f778-473d-97d5-c53923ea9b
 3f/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR CHARLES SHERRINGTON PRIZE LECTURE: Scents and Sensibi
 lity: Representations of Identity\, Illusion and Value in Olfactory Cortex
  - Professor Richard Axel (Columbia University)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:SIR WILFRID LE GROS CLARK PRIZE LECTURE: Cardiovascular Ageing: Un
 raveling the Interplay of Vessels\, Nerves\, and Inflammation - Professor 
 Stefanie Dimmeler (Goethe University\, Frankfurt)
DTSTART;VALUE=DATE-TIME:20240422T160000
DTEND;VALUE=DATE-TIME:20240422T170000
UID:https://new.talks.ox.ac.uk/talks/id/bfc73058-f2f9-42ab-8c6e-908926445e
 76/
DESCRIPTION:Aging poses a significant risk to cardiovascular health and le
 ads to an increase in diastolic and systolic impairment\, endothelial cell
  dysfunction\, hypertrophy\, fibrosis\, and electrophysiological alteratio
 ns\, increasing susceptibility to arrhythmic events in the elderly. The me
 chanisms driving age-associated cardiovascular changes are not fully under
 stood. Our preliminary findings indicate a decline in axon density within 
 the aging heart. Recognizing the pivotal role of neuro-vascular interactio
 ns in maintaining tissue homeostasis\, we hypothesize that a compromised n
 euro-vascular interface contributes to age-related cardiac pathologies. Ou
 r study showed a significant reduction of nerve density in the aging heart
 . We further explored the mechanisms and identified an induction of the re
 pulsive Semaphorin 3a (SEMA3A) in senescent endothelial cells. Eliminating
  senescent cells by senolytics rescued the age-associated decline in nerve
  density\, and ameliorated immune cell invasion and age-associated alterat
 ions in cardiac function. In summary\, our comprehensive investigation unr
 aveal the previously unexplored dynamics of neuro-vascular interactions in
  the aging heart. We suggest that restoring or preserving a functional cro
 ss-talk between neurons and the vasculature holds promise for promoting he
 althy cardiac aging.\n\nSPEAKER BIOGRAPHY\n\nStefanie Dimmeler is born on 
 18.07.1967 in Ravensburg\, Germany. Dr. Dimmeler received her undergraduat
 e\, graduate\, and Ph.D. degree from the University of Konstanz in Konstan
 z (Germany) and then completed a fellowship in Experimental Surgery at the
  University of Cologne and in Molecular Cardiology at the University of Fr
 ankfurt (Germany). She is Professor of Experimental Medicine (since 2001) 
 and Director of the Institute of Cardiovascular Regeneration\, Center for 
 Molecular Medicine at the University of Frankfurt since 2008. \n\nIn the l
 ast years\, she has been invited as a speaker in more than 300 national an
 d international meetings and seminars and has presented various keynote le
 ctures. She also received several awards and is among the top 3 female Sci
 entists in Germany. She is also spokesperson of the “Cardiopulmonary Ins
 titute” (CPI) which is funded by the Excellence Strategy Program of the 
 German Research Foundation and spokesperson of the German Center for Cardi
 ovascular Research (DZHK). She also received three Advanced Investigator G
 rants by the European Research Community (ERC).\n\nHer group elucidates th
 e basic mechanisms underlying cardiovascular disease and vessel growth wit
 h the aim to develop new cellular and pharmacological therapies for improv
 ing the treatment of cardiovascular disease. Ongoing research focuses on e
 pigenetic mechanisms that control cardiovascular repair\, specifically non
 -coding RNAs.\nSpeakers:\nProfessor Stefanie Dimmeler (Goethe University\,
  Frankfurt)
LOCATION:Sherrington Building (Blakemore Lecture Theatre\, Sherrington Bui
 lding)\, off Parks Road OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/bfc73058-f2f9-42ab-8c6e-908926445e
 76/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:SIR WILFRID LE GROS CLARK PRIZE LECTURE: Cardiovascular A
 geing: Unraveling the Interplay of Vessels\, Nerves\, and Inflammation - P
 rofessor Stefanie Dimmeler (Goethe University\, Frankfurt)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:MARIANNE FILLENZ PRIZE LECTURE 2024: Deciphering Neurobiological P
 rocesses of Opioid Addiction towards Novel Interventions  - Prof Yasmin Hu
 rd (Ichan School of Medicine at Mount Sinai)
DTSTART;VALUE=DATE-TIME:20240305T130000Z
DTEND;VALUE=DATE-TIME:20240305T140000Z
UID:https://new.talks.ox.ac.uk/talks/id/9e53d77c-5446-43bc-af4b-10e1172b20
 22/
DESCRIPTION:Decoding the neurobiological underpinnings of psychiatric diso
 rders such as addiction is critically linked to expanding insights obtaine
 d from the human brain which can inform targeted treatments.  The importan
 t need for the development of novel non-addictive medications is particula
 rly critical today to address the persistent opioid and overdose epidemic 
 crisis facing society worldwide. The presentation will provide molecular i
 nsights gained from post-mortem studies of human heroin users and compleme
 ntary mechanistic animal studies that identify specific epigenetic\, neuro
 degenerative and synaptic plasticity biological processes that offer drugg
 able targets for opioid use disorder.\n\nSPEAKER BIOGRAPHY\n\nDr. Yasmin H
 urd is Professor of Psychiatry\, Neuroscience and Pharmacological Sciences
  as well as the Director for the Addiction Institute at the Icahn School o
 f Medicine at Mount Sinai in New York. She is an internationally renowned 
 neuroscientist whose translational research examines the neurobiology of s
 ubstance use disorders and related psychiatric disorders with primary focu
 s on opioid abuse and the developmental effects of cannabis. She is a memb
 er of both the National Academy of Sciences and the National Academy of Me
 dicine.\nSpeakers:\nProf Yasmin Hurd (Ichan School of Medicine at Mount Si
 nai)
LOCATION:Sherrington Building (Blakemore Lecture Theatre\, Sherrington Bui
 lding)\, off Parks Road OX1 3PT
TZID:Europe/London
URL:https://new.talks.ox.ac.uk/talks/id/9e53d77c-5446-43bc-af4b-10e1172b20
 22/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:MARIANNE FILLENZ PRIZE LECTURE 2024: Deciphering Neurobio
 logical Processes of Opioid Addiction towards Novel Interventions  - Prof 
 Yasmin Hurd (Ichan School of Medicine at Mount Sinai)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR